Kuangli Bio-Tech Holdings Co., Ltd. · TWSE:6431

Kuangli Bio-Tech Holdings Co., Ltd. financial statements

Kuangli Bio-Tech Holdings Co., Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue377.0M381.3M293.4M342.2M358.2M152.8M425.3M100.1M106.6M210.7M
Cost of revenue306.6M313.0M227.1M273.5M266.7M152.9M413.3M107.9M215.2M460.5M
Gross profit70.4M68.3M66.3M68.7M91.5M-148.0K12.0M-7.84M-108.6M-249.8M
Research and development33.3M32.3M30.8M32.3M11.5M3.24M8.30M5.81M6.31M7.77M
Selling, general and administrative89.5M89.8M94.2M96.4M72.5M57.6M41.8M25.6M27.2M44.6M
Operating income-157.5M-138.1M-113.7M-70.2M64.7M-59.3M-24.6M-44.7M-147.8M-311.8M
Depreciation and amortization86.9M83.9M60.6M60.7M39.9M7.77M7.74M868.0K50.6M72.5M
EBITDA-70.6M-54.2M-53.0M-9.48M104.6M-51.5M-16.9M-43.8M-97.2M-239.3M
Interest expense13.7M15.9M14.2M14.3M8.21M62.0K389.0K000
Income before tax-193.0M-182.4M-123.7M-84.8M60.7M-59.5M-24.6M-17.7M-158.9M-280.1M
Income tax-9.60M-19.5M-13.8M4.80M3.36M2.98M1.19M-106.0K-8.73M
Net income-193.0M-172.8M-104.2M-71.0M55.9M-62.9M-27.5M-18.9M-158.8M-271.4M
Earnings per share, basic-2.07-2.52-1.82-1.261.10-1.37-0.60-0.41-3.47-5.93

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents208.9M41.6M63.2M141.9M162.2M114.4M129.0M253.7M247.9M238.8M
Short-term investments101.2M27.6M21.2M20.9M30.0M92.1M117.2M176.8M
Receivables82.3M115.2M135.9M163.3M231.5M51.8M265.5M50.1M47.2M84.3M
Inventory46.6M57.5M58.1M62.8M97.4M9.59M8.95M10.4M17.0M22.4M
Current assets463.8M249.2M305.7M399.8M523.1M179.8M440.1M416.4M442.6M539.8M
Property, plant and equipment361.4M368.5M22.1M14.8M7.70M7.40M94.7M
Goodwill98.9M107.2M128.8M140.4M138.4M0
Total assets1.19B910.2M1.04B1.12B1.25B378.0M555.4M446.7M475.2M666.3M
Accounts payable49.2M56.5M22.4M29.7M95.2M32.0M145.8M12.2M8.30M12.6M
Current liabilities342.3M308.0M283.1M272.7M328.2M56.3M202.5M47.9M50.0M67.6M
Long-term debt6.17M6.25M21.4M12.2M0
Total debt487.3M336.8M421.5M349.8M348.3M7.55M4.67M
Total liabilities607.0M450.2M485.3M442.8M506.6M64.2M203.5M48.0M50.3M74.6M
Shareholders' equity577.4M460.0M557.9M672.7M482.3M313.8M351.9M398.7M424.9M591.8M
Shares outstanding93.2M68.6M57.2M56.4M50.8M45.8M45.8M45.8M45.8M45.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-145.3M-65.2M-62.4M-9.24M21.7M8.50M-91.6M-22.3M-48.2M10.1M
Capital spending-9.14M-17.4M-25.2M-34.2M-40.6M-8.51M-3.02M-118.0K-3.12M-17.0M
Free cash flow-154.5M-82.7M-87.6M-43.5M-18.9M-10.0K-94.7M-22.4M-51.3M-6.93M
Cash from investing14.1M62.3M-30.5M-3.16M-93.4M-35.5M-18.5M36.7M64.4M-187.8M
Cash from financing314.1M-16.1M17.5M-11.1M121.0M11.6M-4.91M-4.91M-4.91M-4.91M
Change in cash167.3M-21.6M-78.7M-20.3M47.7M-14.6M-124.6M5.79M9.04M-224.3M